Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Amarantus Bioscience Holdings, Inc (AMBS)

-Other OTC
0.07 Down 0.00(0.43%) Apr 17, 3:59PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Amarantus Bioscience Holdings, Inc
675 Almanor Avenue
Sunnyvale, CA 94085
United States - Map
Phone: 408-737-2734
Fax: 408-852-4427
Website: http://www.amarantus.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:3

Business Summary 

Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States. The company is developing the Mesencephalic-Astrocyte-derived Neurotrophic Factor, a therapeutic protein to treat Parkinson’s diseases, as well as for other apoptosis-related disorders, including ischemic heart disease, traumatic brain injury, and orphan diseases; LymPro, blood test to diagnose Alzheimer’s disease; NuroPro to diagnose neurodegenerative diseases; and BC-SeraPro to diagnose breast cancer. It also owns PhenoGuard cell lines for the screening and discovery of biologic drug candidates and biomarkers of the central nervous system. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus Bioscience Holdings, Inc. in April 2013. Amarantus Bioscience Holdings, Inc. was founded in 2008 and is based in Sunnyvale, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Amarantus Bioscience Holdings, Inc

Key Executives 
 PayExercised
Mr. Gerald E. Commissiong , 32
Chief Exec. Officer, Pres and Director
0.000.00
Dr. John W. Commissiong Ph.D., 70
Chief Scientific Officer and Director
0.000.00
Mr. Marc E. Faerber , 59
VP of Financial Operations and Corp. Controller
260.00K0.00
Mr. Robert E. Farrell J.D., Esq., 64
Chief Financial Officer
N/AN/A
Aimee Boutcher ,
Director of Investor Relations
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders